The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice
The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Abstract
This set of recommendations from ISSHP is designed to assist clinicians throughout the world in the recognition and management of the hypertensive disorders of pregnancy; the document includes sections written by those working in low and middle income countries so as to ensure applicability in all parts of the world. Some key points include: ISSHP does not recommend classifying pre-eclampsia as ‘mild’ or ‘severe’ because the condition may progress rapidly and unpredictably. Proteinuria is not mandatory for a diagnosis of pre-eclampsia. The HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low platelets) is one (serious) manifestation of pre-eclampsia and not a separate disorder. ISSHP supports first trimester screening for risk of pre-eclampsia when this can be integrated into the local health system, although the cost effectiveness of this approach remains to be established. ISSHP recommends that women with established strong clinical risk factors for pre-eclampsia (i.e., prior pre-eclampsia, chronic hypertension, pre-gestational diabetes, maternal BMI >30 kg/m2, antiphospholipid syndrome and receipt of assisted reproduction) be treated, ideally before 16 weeks but definitely before 20 weeks, with low dose aspirin (defined as 75–162 mg/day, as studied in RCTs). ISSHP recommends at this stage against the routine clinical use of ‘rule-in’ or ‘rule-out’ tests (specifically PlGF or sFLT-1/PlGF ratio) for pre-eclampsia. Regardless of the hypertensive disorder of pregnancy, blood pressure requires urgent treatment in a monitored setting when severe (>160/110 mmHg). For pre-eclampsia, target diastolic blood pressure is 85 mmHg in the office/clinic (and systolic blood pressure of 110–140 mmHg). Women with pre-eclampsia who have proteinuria and severe hypertension, or hypertension with neurological signs or symptoms, should receive magnesium sulphate (MgSO4) for convulsion prophylaxis. Annual medical review is advised life-long and all such women should adopt a healthy lifestyle that includes exercise, eating well and aiming for ideal body weight.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2013) · doi:10.1097/01.aog.0000437382.03963.88 · Cited by 3,961
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Self-citationCirculating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. J. (2007) · BMJ · doi:10.1136/bmj.39335.385301.be · Cited by 2,552 · cited 1×
“• Advice to women with gestational hypertension or preeclampsia that they have increased risks of cardiovascular disease, death, stroke [33,101,102], diabetes, venous thromboembolic disease (VTE) and CKD compared with women who have had normotensive pregnancies [103].”
BackgroundAspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Rolnik, D. L., Wright, D., Poon, L. C., O’Gorman, N., Syngelaki, A., de Paco Matallana, C., Akolekar, R., Cicero, S., Janga, D., Singh, M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1704559 · Cited by 2,287
Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia
Zeisler, H., Llurba, E., Chantraine, F., Vatish, M., Staff, A. C., Sennström, M., Olovsson, M., Brennecke, S. P., Stepan, H., Allegranza, D., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1414838 · Cited by 1,783
Tranquilli, A. L., Dekker, G., Magee, L., Roberts, J., Sibai, B. M., Steyn, W., Zeeman, G. G., & Brown, M. A. (2014) · Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health · doi:10.1016/j.preghy.2014.02.001 · Cited by 1,417
Self-citationBujold, E., Roberge, S., Lacasse, Y., Bureau, M., Audibert, F., Marcoux, S., Forest, J.-C., & Giguère, Y. (2010) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181e9322a · Cited by 1,092
Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Hofmeyr, G. J., Lawrie, T. A., Atallah, Á. N., & Duley, L. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001059.pub3 · Cited by 1,062
Cited by
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Pre-eclampsia: pathophysiology and clinical implications
Burton, G. J., Redman, C. W., Roberts, J. M., & Moffett, A. (2019) · BMJ · doi:10.1136/bmj.l2381 · Cited by 1,250
Poon, L. C., Shennan, A., Hyett, J. A., Kapur, A., Hadar, E., Divakar, H., McAuliffe, F., da Silva Costa, F., von Dadelszen, P., McIntyre, H. D., et al. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12802 · Cited by 1,238
Magee, L. A., Brown, M. A., Hall, D. R., Gupte, S., Hennessy, A., Karumanchi, S. A., Kenny, L. C., McCarthy, F., Myers, J., Poon, L. C., et al. (2022) · Pregnancy Hypertension · doi:10.1016/j.preghy.2021.09.008 · Cited by 1,134
Self-citationDiretrizes Brasileiras de Hipertensão Arterial – 2020
Barroso, W. K. S., Rodrigues, C. I. S., Bortolotto, L. A., Mota-Gomes, M. A., Brandão, A. A., Feitosa, A. D. D. M., Machado, C. A., Poli-de-Figueiredo, C. E., Amodeo, C., Mion, D., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201238 · Cited by 1,068
Dimitriadis, E., Rolnik, D. L., Zhou, W., Estrada-Gutierrez, G., Koga, K., Francisco, R. P. V., Whitehead, C., Hyett, J., da Silva Costa, F., Nicolaides, K., et al. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00417-6 · Cited by 866
Preeclampsia—Pathophysiology and Clinical Presentations
Ives, C. W., Sinkey, R., Rajapreyar, I., Tita, A. T. N., & Oparil, S. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.014 · Cited by 860
The two-stage placental model of preeclampsia: An update
Staff, A. C. (2019) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2019.07.004 · Cited by 598
Maas, A. H. E. M., Rosano, G., Cifkova, R., Chieffo, A., van Dijken, D., Hamoda, H., Kunadian, V., Laan, E., Lambrinoudaki, I., Maclaran, K., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa1044 · Cited by 344
Leon, L. J., McCarthy, F. P., Direk, K., Gonzalez-Izquierdo, A., Prieto-Merino, D., Casas, J. P., & Chappell, L. (2019) · Circulation · doi:10.1161/circulationaha.118.038080 · Cited by 329
Self-citationPreeclampsia Prevalence, Risk Factors, and Pregnancy Outcomes in Sweden and China
Yang, Y., Le Ray, I., Zhu, J., Zhang, J., Hua, J., & Reilly, M. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.8401 · Cited by 307
Conde-Agudelo, A., & Romero, R. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.07.009 · Cited by 289
Maher, G. M., O’Keeffe, G. W., Kearney, P. M., Kenny, L. C., Dinan, T. G., Mattsson, M., & Khashan, A. S. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0854 · Cited by 271
Self-citationChang, K.-J., Seow, K.-M., & Chen, K.-H. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20042994 · Cited by 266
Hypertension in pregnancy: Pathophysiology and treatment
Braunthal, S., & Brateanu, A. (2019) · SAGE Open Medicine · doi:10.1177/2050312119843700 · Cited by 263
Fishel Bartal, M., & Sibai, B. M. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.09.037 · Cited by 255
Stepan, H., Galindo, A., Hund, M., Schlembach, D., Sillman, J., Surbek, D., & Vatish, M. (2023) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.26032 · Cited by 245
Preeclampsia in 2018: Revisiting Concepts, Physiopathology, and Prediction
Mayrink, J., Costa, M. L., & Cecatti, J. G. (2018) · The Scientific World Journal · doi:10.1155/2018/6268276 · Cited by 237
“According to the concept proposed by the International Society for Studies in Gestational Hypertension, published in 2014 and reinforced in 2018 [24], every hypertensive pregnant woman should be investigated for multiple organ involvement, even if presenting negative proteinuria, in order to discard the hypothesis of…”
Proteinuria during pregnancy: definition, pathophysiology, methodology, and clinical significance
Fishel Bartal, M., Lindheimer, M. D., & Sibai, B. M. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.08.108 · Cited by 167
Palmer, K. R., Tanner, M., Davies-Tuck, M., Rindt, A., Papacostas, K., Giles, M. L., Brown, K., Diamandis, H., Fradkin, R., Stewart, A. E., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00668-1 · Cited by 121
Lai, J., Syngelaki, A., Nicolaides, K. H., von Dadelszen, P., & Magee, L. A. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.11.004 · Cited by 89
Self-citationEvaluation of the clinical impact of the revised ISSHP and ACOG definitions on preeclampsia
Bouter, A. R., & Duvekot, J. J. (2020) · Pregnancy Hypertension · doi:10.1016/j.preghy.2019.11.011 · Cited by 77
Gestational Hypertension and Preeclampsia: An Overview of National and International Guidelines
Tsakiridis, I., Giouleka, S., Arvanitaki, A., Giannakoulas, G., Papazisis, G., Mamopoulos, A., Athanasiadis, A., & Dagklis, T. (2021) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000942 · Cited by 64
Reddy, M., Fenn, S., Rolnik, D. L., Mol, B. W., da Silva Costa, F., Wallace, E. M., & Palmer, K. R. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.08.019 · Cited by 61
Impact of new definitions of pre‐eclampsia on incidence and performance of first‐trimester screening
Khan, N., Andrade, W., De Castro, H., Wright, A., Wright, D., & Nicolaides, K. H. (2020) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.21867 · Cited by 59
Maternal microbiome in preeclampsia pathophysiology and implications on offspring health
Ishimwe, J. A. (2021) · Physiological Reports · doi:10.14814/phy2.14875 · Cited by 45
“…through the following features: proteinuria (≥300 mg/ 24 h) or protein (mg/dl)/creatinine ratio (mg/dl) ≥0.3, hemolysis, elevated liver enzymes and low platelet count ( 100,000/ μl), neurological or visual symptoms, abnormal Doppler ultrasound, and fetal growth restriction (Brown et al., 2018).”
BackgroundInfluentialPitz Jacobsen, D., Fjeldstad, H. E., Johnsen, G. M., Fosheim, I. K., Moe, K., Alnæs-Katjavivi, P., Dechend, R., Sugulle, M., & Staff, A. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.791606 · Cited by 36
Maher, G. M., Dalman, C., O’Keeffe, G. W., Kearney, P. M., McCarthy, F. P., Kenny, L. C., & Khashan, A. S. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13162 · Cited by 35
Self-citationMalone, S. L., Haj Yahya, R., & Kane, S. C. (2022) · International Journal of Women's Health · doi:10.2147/ijwh.s283239 · Cited by 32
“Most international bodies have not updated guidance regarding screening since the advent of multiparametric screening: ISSHP has acknowledged and supported the use of multiparametric screening when it can be integrated into the healthcare system and otherwise suggest risk factor screening.(5) FIGO, however, has embrac…”
BackgroundPre-eclampsia: a Scoping Review of Risk Factors and Suggestions for Future Research Direction
Lee, K., Brayboy, L., & Tripathi, A. (2022) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-021-00243-w · Cited by 23
Magee, L., Singer, J., Lee, T., Rey, E., Asztalos, E., Hutton, E., Helewa, M., Logan, A., Ganzevoort, W., Welch, R., et al. (2021) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16602 · Cited by 21
Self-citationPrognosis Associated with Sub-Types of Hyperglycaemia in Pregnancy
Cosson, E., Bentounes, S. A., Nachtergaele, C., Berkane, N., Pinto, S., Sal, M., Bihan, H., Tatulashvili, S., Portal, J.-J., Carbillon, L., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173904 · Cited by 20
Metadata
- Authors
- Brown, M. A., Magee, L. A., Kenny, L. C., Karumanchi, S. A., McCarthy, F. P., Saito, S., Hall, D. R., Warren, C. E., Adoyi, G., & Ishaku, S.
- Venue
- Pregnancy Hypertension
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 13
- Pages
- 291-310
- ISSN
- 2210-7789 (ISSN-L)
- OpenAlex
- W3022285062
- Cited by
- 1,067
- References
- 113
- FWCI
- 91.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.